<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">33202330</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>04</Month>
        <Day>23</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>07</Month>
        <Day>15</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1532-818X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>42</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2021</Year>
              <Season>Jan-Feb</Season>
            </PubDate>
          </JournalIssue>
          <Title>American journal of otolaryngology</Title>
          <ISOAbbreviation>Am J Otolaryngol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Meniere's disease: Medical management, rationale for vestibular preservation and suggested protocol in medical failure.</ArticleTitle>
        <Pagination>
          <StartPage>102817</StartPage>
          <MedlinePgn>102817</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.amjoto.2020.102817</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0196-0709(20)30511-1</ELocationID>
        <Abstract>
          <AbstractText>Meniere's disease is a peripheral audiovestibular disorder characterized by vertigo, hearing loss, tinnitus, and aural fullness. Management of these symptoms includes medical and surgical treatment. Many patients with Meniere's disease can be managed using nonablative therapy, such as intratympanic steroids and endolymphatic shunt surgery, prior to ablative techniques such as intratympanic gentamicin. Recognition of concurrent migraine symptoms may aid in medical therapy and also underscore the importance of preserving vestibular function where possible. The goal of this review is to explain the importance of nonablative therapy options and discuss treatment protocols after medical failure.</AbstractText>
          <CopyrightInformation>Copyright Â© 2020. Published by Elsevier Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Christopher</LastName>
            <ForeName>Laura H</ForeName>
            <Initials>LH</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Neurotology, House Ear Clinic, United States of America. Electronic address: lchristopher@houseclinic.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wilkinson</LastName>
            <ForeName>Eric P</ForeName>
            <Initials>EP</Initials>
            <AffiliationInfo>
              <Affiliation>House Ear Clinic, House Institute Foundation, United States of America. Electronic address: ewilkinson@houseclinic.com.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>11</Month>
          <Day>02</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Am J Otolaryngol</MedlineTA>
        <NlmUniqueID>8000029</NlmUniqueID>
        <ISSNLinking>0196-0709</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D005839">Gentamicins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>7S5I7G3JQL</RegistryNumber>
          <NameOfSubstance UI="D003907">Dexamethasone</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="CommentIn">
          <RefSource>Am J Otolaryngol. 2021 May-Jun;42(3):102939</RefSource>
          <PMID Version="1">33516617</PMID>
        </CommentsCorrections>
      </CommentsCorrectionsList>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D003907" MajorTopicYN="N">Dexamethasone</DescriptorName>
          <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004713" MajorTopicYN="N">Endolymphatic Shunt</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005839" MajorTopicYN="N">Gentamicins</DescriptorName>
          <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008575" MajorTopicYN="N">Meniere Disease</DescriptorName>
          <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D059351" MajorTopicYN="N">Organ Sparing Treatments</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017211" MajorTopicYN="N">Treatment Failure</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014722" MajorTopicYN="N">Vestibule, Labyrinth</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Endolymphatic hydrops</Keyword>
        <Keyword MajorTopicYN="N">Endolymphatic sac shunt</Keyword>
        <Keyword MajorTopicYN="N">Intratympanic gentamicin</Keyword>
        <Keyword MajorTopicYN="N">Intratympanic steroid</Keyword>
        <Keyword MajorTopicYN="N">Meniere's disease</Keyword>
        <Keyword MajorTopicYN="N">Treatment of Meniere's disease</Keyword>
        <Keyword MajorTopicYN="N">Vestibular migraine</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>8</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>10</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>10</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2020</Year>
          <Month>11</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>4</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>11</Month>
          <Day>17</Day>
          <Hour>20</Hour>
          <Minute>7</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">33202330</ArticleId>
        <ArticleId IdType="doi">10.1016/j.amjoto.2020.102817</ArticleId>
        <ArticleId IdType="pii">S0196-0709(20)30511-1</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
